Table 3.
Outcome: CRP | Regression coefficient | std. error | p-value | Df |
---|---|---|---|---|
Predictor | ||||
A+FN | 17.144 | 2.541 | <0.001 | 23 |
TFN | −0.09 | 0.14 | 0.52 | 23 |
%A+ | 9135.321 | 920.837 | <0.001 | 23 |
VWF | 0.215 | 0.069 | 0.005 | 23 |
Outcome: VWF | regression coefficient | std. error | p-value | Df |
Predictor | ||||
A+FN | 13.203 | 6.1 | 0.037 | 35 |
TFN | 0.051 | 0.2 | 0.80 | 35 |
%A+ | 8345.609 | 2695.398 | 0.004 | 35 |
The response variable is listed as the “outcome”. Vasculitis status is not included as a predictor. The random effect was included on the intercept. A+FN refers to the plasma concentration (μg/ml) of FN isoforms bearing the EIIIA segment. TFN refers to the total concentration (μg/ml) of FN in plasma. %A+ refers to the percentage of TFN comprised of A+FN isoforms. vWF and CRP respectively refer to the plasma concentrations of vWF and CRP, expressed as the % of the average value in healthy individuals.